Cargando…
A single-blind, dose-escalation, phase I study of high-fluence light-emitting diode-red light on Caucasian non-Hispanic skin: study protocol for a randomized controlled trial
BACKGROUND: Visible light (400 to 700 nm) is common in our environment, comprising 44% of total solar radiation and a large component of environmental light exposure. The effects of visible light on skin remain undefined. The red light portion of the visible spectrum (600 to 700 nm) may be used to t...
Autores principales: | Wang, Erica B., Kaur, Ramanjot, Nguyen, Julie, Ho, Derek, Austin, Evan, Maverakis, Emanual, Li, Chin-Shang, Hwang, Samuel T., Isseroff, R. Rivkah, Jagdeo, Jared |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6425608/ https://www.ncbi.nlm.nih.gov/pubmed/30894210 http://dx.doi.org/10.1186/s13063-019-3278-7 |
Ejemplares similares
-
A single-blind, dose escalation, phase I study of high-fluence light-emitting diode-red light (LED-RL) on human skin: study protocol for a randomized controlled trial
por: Ho, Derek, et al.
Publicado: (2016) -
Resveratrol Prevents High Fluence Red Light-Emitting Diode Reactive Oxygen Species-Mediated Photoinhibition of Human Skin Fibroblast Migration
por: Mamalis, Andrew, et al.
Publicado: (2015) -
Red Light Phototherapy Using Light-Emitting Diodes Inhibits Melanoma Proliferation and Alters Tumor Microenvironments
por: Austin, Evan, et al.
Publicado: (2022) -
Transcriptome analysis of human dermal fibroblasts following red light phototherapy
por: Austin, Evan, et al.
Publicado: (2021) -
A dose-ranging, parallel group, split-face, single-blind phase II study of light emitting diode-red light (LED-RL) for skin scarring prevention: study protocol for a randomized controlled trial
por: Nguyen, Julie K., et al.
Publicado: (2019)